Detailed Information
Cited 7 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR
- Authors
- Artal-Cortes, A[Artal-Cortes, A.]; Mazieres, J[Mazieres, J.]; Fehrenbacher, L[Fehrenbacher, L.]; Rittmeyer, A[Rittmeyer, A.]; Spira, AI[Spira, A. I.]; Park, K[Park, K.]; Lewanski, C[Lewanski, C.]; Liu, S[Liu, S.]; Ballinger, M[Ballinger, M.]; Vansteenkiste, J[Vansteenkiste, J.]
- Issue Date
- Apr-2017
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.28
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 28
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.